ClinicalTrials.Veeva

Menu

Effects of a Smartphone-Supported Daily Walking Intervention on Psychological Well-Being and Body Composition in Adults With Cardiometabolic Disease (DAILY-WALK)

K

Klaipėda University

Status

Completed

Conditions

Cardiovascular Disease Prevention

Treatments

Behavioral: Smartphone-Supported Daily Walking

Study type

Interventional

Funder types

Other

Identifiers

NCT07674459
KU-Walk15

Details and patient eligibility

About

This study evaluated whether a three-month smartphone-supported daily walking intervention could improve physical activity, psychological well-being, and body composition in adults with cardiometabolic disease. Participants had cardiovascular disease and/or type 2 diabetes and used the Walk15 smartphone platform to monitor daily step count. The intervention aimed to increase daily walking by approximately 1,000 steps per day through individualized step goals, self-monitoring, and digital feedback. Outcomes were assessed before and after the intervention and included daily step count, body composition, handgrip strength, sleep duration, eating behaviors, subjective well-being, vigor, stress, anxiety, health, and happiness.

Full description

This was a three-month quasi-experimental longitudinal study in adults aged 20 to 65 years with physician-confirmed cardiovascular disease and/or type 2 diabetes mellitus. The intervention was delivered through the Walk15 smartphone platform. Participants received individualized step goals based on baseline activity levels and were encouraged to increase daily walking gradually, aiming for approximately 1,000 additional steps per day. Daily step counts were monitored through smartphone-connected wearable devices and synchronized with the Walk15 platform. No dietary modifications, weight-loss program, or structured exercise training were prescribed. The study assessed changes in physical activity, psychological well-being, lifestyle behaviors, muscle strength, and body composition from baseline to the end of the three-month intervention.

Enrollment

419 patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 20 to 65 years Physician-confirmed diagnosis of cardiovascular disease and/or type 2 diabetes mellitus verified through medical records Medical clearance from the treating physician confirming that participation in a walking-based physical activity program was safe and appropriate Ability to use the Walk15 smartphone platform or smartphone-connected wearable device for step-count monitoring Written informed consent provided before enrollment

Exclusion criteria

  • Severe mobility limitations Acute medical conditions Psychiatric disorders requiring pharmacological treatment Inability to complete baseline or post-intervention assessments

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

419 participants in 1 patient group

Smartphone-Supported Daily Walking Intervention Arm Type
Experimental group
Description:
Participants received a three-month smartphone-supported walking intervention delivered through the Walk15 platform. Individualized step goals were established based on baseline activity levels, and participants were encouraged to increase daily walking by approximately 1,000 steps per day. Daily step counts were monitored using smartphone-connected wearable devices and synchronized with the Walk15 platform.
Treatment:
Behavioral: Smartphone-Supported Daily Walking

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems